Pfizer CEO Albert Bourla joins CNBC's 'Special Report' as President-elect Donald Trump is inaugurated as the 47th U.S.

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

Topics up for discussion range from carbon pricing and the economics of nature to changing weather patterns and upcoming ...

It’s not just the tech billionaires descending on Washington. Plenty of chief executives from other industries are also ...

Dealmaking, deregulation and threats to global trade are expected to dominate the conversation among executives gathering in Davos this week, as Donald Trump’s return to the White House shifts the ...

Washington, DC, is set to host the inauguration of Donald Trump's second term, featuring wealthy supporters like Elon Musk, ...

Paul Kong is joining the International Legal Finance Association, which represents litigation finance firms, as the group’s ...

The World Economic Forum’s Annual Meeting agenda promises to cover sustainability and energy issues from the environment to people and new technologies ...